MY8000064A - M-dioxane-5-methylamine analgesics - Google Patents

M-dioxane-5-methylamine analgesics

Info

Publication number
MY8000064A
MY8000064A MY64/80A MY8000064A MY8000064A MY 8000064 A MY8000064 A MY 8000064A MY 64/80 A MY64/80 A MY 64/80A MY 8000064 A MY8000064 A MY 8000064A MY 8000064 A MY8000064 A MY 8000064A
Authority
MY
Malaysia
Prior art keywords
analgesics
methylamine
dioxane
methylamine analgesics
Prior art date
Application number
MY64/80A
Other languages
English (en)
Inventor
Richard Nolan Booher
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MY8000064A publication Critical patent/MY8000064A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MY64/80A 1972-12-08 1980-12-30 M-dioxane-5-methylamine analgesics MY8000064A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31322172A 1972-12-08 1972-12-08

Publications (1)

Publication Number Publication Date
MY8000064A true MY8000064A (en) 1980-12-31

Family

ID=23214841

Family Applications (1)

Application Number Title Priority Date Filing Date
MY64/80A MY8000064A (en) 1972-12-08 1980-12-30 M-dioxane-5-methylamine analgesics

Country Status (27)

Country Link
JP (2) JPS5742633B2 (fr)
AR (3) AR206306A1 (fr)
AT (2) AT330773B (fr)
BE (1) BE808340A (fr)
BG (4) BG22386A3 (fr)
CA (2) CA1014560A (fr)
CH (4) CH605903A5 (fr)
CS (3) CS222209B2 (fr)
CY (1) CY1017A (fr)
DD (3) DD110864A5 (fr)
DE (1) DE2361340C2 (fr)
DK (1) DK134717B (fr)
ES (4) ES421290A1 (fr)
FR (1) FR2209578B1 (fr)
GB (2) GB1455998A (fr)
HK (1) HK60479A (fr)
HU (2) HU168763B (fr)
IE (1) IE40226B1 (fr)
IL (1) IL43773A (fr)
KE (1) KE2976A (fr)
MY (1) MY8000064A (fr)
NL (1) NL7316839A (fr)
PH (2) PH15197A (fr)
SE (3) SE403377B (fr)
SU (4) SU578001A3 (fr)
YU (3) YU36171B (fr)
ZA (1) ZA739207B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2847177B1 (fr) * 2012-05-09 2017-10-11 Boehringer Ingelheim International GmbH Methodes pour la preparation d'oxetan-3-ylmethanamines
LV14983B (lv) * 2013-10-15 2015-06-20 Olainfarm, A/S Fenibuta ražošanas starpproduktu iegūšanas paņēmiens

Also Published As

Publication number Publication date
ES444911A1 (es) 1977-09-01
YU35447B (en) 1981-02-28
ZA739207B (en) 1975-07-30
NL7316839A (fr) 1974-06-11
CA1014560A (en) 1977-07-26
DD109625A5 (fr) 1974-11-12
SE7701795L (sv) 1977-02-17
ES421291A1 (es) 1976-07-01
ES421290A1 (es) 1976-07-01
YU318473A (en) 1980-09-25
SE403377B (sv) 1978-08-14
IL43773A (en) 1979-05-31
HU168763B (fr) 1976-07-28
SE7701796L (sv) 1977-02-17
HU168620B (fr) 1976-06-28
CS222209B2 (en) 1983-05-27
IE40226L (en) 1974-06-08
AU6321773A (en) 1975-06-05
FR2209578B1 (fr) 1977-09-02
DE2361340C2 (de) 1983-11-24
JPS5734835B2 (fr) 1982-07-26
ES444716A1 (es) 1977-05-16
DK134717C (fr) 1977-05-31
DD115653A5 (fr) 1975-10-12
GB1455998A (en) 1976-11-17
CS222208B2 (en) 1983-05-27
CH619219A5 (en) 1980-09-15
AR212416A1 (es) 1978-07-14
YU318573A (en) 1981-06-30
DD110864A5 (fr) 1975-01-12
ATA1026173A (de) 1976-01-15
SU587861A3 (ru) 1978-01-05
CH605903A5 (fr) 1978-10-13
PH15197A (en) 1982-09-17
SU648081A3 (ru) 1979-02-15
BG26205A4 (bg) 1979-02-15
CY1017A (en) 1979-11-23
AR206306A1 (es) 1976-07-15
SU663305A3 (ru) 1979-05-15
HK60479A (en) 1979-08-31
ATA1026073A (de) 1975-10-15
BG21409A3 (bg) 1976-05-20
JPS4987680A (fr) 1974-08-22
IL43773A0 (en) 1974-03-14
CA1024150A (fr) 1978-01-10
CH614439A5 (en) 1979-11-30
CS193480B2 (en) 1979-10-31
DK134717B (da) 1977-01-03
YU36171B (en) 1982-02-25
BE808340A (fr) 1974-06-07
JPS4987681A (fr) 1974-08-22
DE2361340A1 (de) 1974-06-12
YU36020B (en) 1981-11-13
GB1455997A (en) 1976-11-17
SE428378B (sv) 1983-06-27
AT330773B (de) 1976-07-26
IE40226B1 (en) 1979-04-11
YU109380A (en) 1981-04-30
BG21223A3 (bg) 1976-03-20
SE417196B (sv) 1981-03-02
AT332396B (de) 1976-09-27
KE2976A (en) 1979-07-20
SU578001A3 (ru) 1977-10-25
BG22386A3 (bg) 1977-02-20
PH14923A (en) 1982-01-29
JPS5742633B2 (fr) 1982-09-09
FR2209578A1 (fr) 1974-07-05
AR212012A1 (es) 1978-04-28
CH630914A5 (en) 1982-07-15

Similar Documents

Publication Publication Date Title
CS609973A2 (en) Nosic informace
CS283873A2 (en) Zpusob rafinace tavenin zeleznych kovu
GB1405253A (en) 1- 2-substituted-chromonyloxy-w-hydroxy-3-phenoxy-propanes
AU6329873A (en) Flameprofing
GB1407713A (en) 2-alkoxy-cephalosporins
AU5993373A (en) N-sulphenylated carbamidoximes
AU6362373A (en) N-propargylacetanilide herbicedes
GB1402226A (en) 3-cyanochromones
GB1401579A (en) Indolo-quinolizines
PL177258A1 (en) Sposob wytwarzania nowych benzenosulfonylomocznikow
GB1408010A (en) Sulphamoylphenyl-imidazolidinones
AU5233473A (en) Nitro-imidazolyl-pyrimidines
AU6332973A (en) Bulbholders
AU5711073A (en) Benzenesulfonyl-ureas benzenesulfonyl-ureas
GB1401735A (en) Imino-lactams
AU5191873A (en) Benzylpyrimidines
GB1400667A (en) 4-spirocyclopropyl-androstenes
AU5983773A (en) Alkylsulphonyl-2-trifluoromethyl-benzimidazoles
GB1405254A (en) Bis- substituted-henoxy- propanes
ZA732238B (en) Benzylamine analgesics
ZA739207B (en) M-dioxane-5-methylamine analgesics
GB1402045A (en) 11-o-methanesulphonylerythromycins
AU5900173A (en) Thiazolopyrimidines
GB1415691A (en) Bracks
GB1400604A (en) 2-acyl-5-nitrothiazoles